Fort spa

Roman name

No-Spa forte

The composition and the form of

Solution for injection-1 amp.drotaverina hydrochloride-40 megawatts ml to 2 ml; In a Box 5, or 25 St.tabletki-1 tabl.drotaverina hydrochloride-40 megawatts blistere 20 pcs. ; In a box one blister or container 100 pcs. ; in a Box 1 Conteiner.rastvor injection-1 amp.drotaverina hydrochloride-80 megawatts sealed dark glass to 4 ml; blistere in five vials; in the paper cartons 1 or 5 Blisterov.tabletki-1 tabl.drotaverina hydrochloride-80 megawatts blistere 10 pcs. ; in a box 1 or 2 blisters.

Pharmacokinetics

Fully and rapidly absorbed from the digestive tract. C_max achieved in 2 hours Associated with the plasma protein to 95-98%. T_1/2 after in / introductions at 2.4 hours Most of the displays with urine, the remainder from faeces.

Indications

Cramps : smooth muscles syndrome (hospital disease stomach and duodenal ulcer, gastritis, enteritis, colitis, cramps and cardia privratnika, irritated syndrome large bowel, spasticeski constipation or bloating, pancreatitis), jelche- and urinary tract (cholelithiasis, holangiolitiaz, holetsistit, periholetsistit, holangit, papillit, stone, uretrolitiaz, pielit, anesthetic, tenezma bladder); Gynaecological disease (dismenorea, adneksit, severe pain in childbirth threatens abortion), headache vascular origin.

Contraindications

Hypersensitivity or serious liver, kidney or heart failure, AV blockade II degree.

Side-Effects

Headache, dizziness, palpitations, nausea, arterial gipotenzia (with Injecting a).

Patient interaction

Ters antiparkinsoniceski effect of levodopa.

Precautions

It should refrain from driving vehicles and other potentially dangerous activities within 1 h after injection (especially / c) introduction.

Storage conditions

With an ambient temperature of 15 to 25 ° C

Shelf life

5 years

The registration

015632/01

Directory → Organotropona funds → Spazmolitiki miotropona → Fort spa